The Effect of Personalized Shoe Insole on the Gait of Parkinson's Disease Subjects
InsolePD
1 other identifier
interventional
42
1 country
1
Brief Summary
This study aims to assess the efficacy of custom-made shoe insoles, for subjects with Parkinson's Disease (PD). To do that, a sample of PD subjects has been randomly assigned to an intervention group that will receive the custom-made insoles or a control group that will receive a sham insole without any specific manufacturing. Both groups will receive Physiotherapy and Occupational Therapy according to PD rehabilitation guidelines. The principal outcome will be the Time Up\&Go test time, secondary outcomes 10 Meters Walking test speed, Berg Balance Scale score, SF12 score, and orthesis liking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Mar 2021
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2021
CompletedStudy Start
First participant enrolled
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedOctober 3, 2023
September 1, 2023
1.8 years
March 4, 2021
October 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Time Up&Go test
Change from Baseline (without insoles (T0) and with insoles (T1)) Time Up\&Go at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Baseline, at 10 weeks, and at 16 weeks.
Secondary Outcomes (15)
Change in 10 Meters walking test Speed
Baseline, at 10 weeks, and at 16 weeks.
Change in Berg Balance Scale Score
Baseline, at 10 weeks, and at 16 weeks.
Change in Short-Form12 score
Baseline, at 10 weeks, and at 16 weeks.
Change in Likert scale 4 points
Baseline, at 10 weeks, and at 16 weeks.
Change in 10 Meters Walking Test cadence
Baseline, at 10 weeks, and at 16 weeks.
- +10 more secondary outcomes
Study Arms (2)
Custom-Made Insole
EXPERIMENTALThis Group will receive a custom-made shoe insole designed on the foot shape of the subjects. The group will also receive Physiotherapy and Occupational Therapy according to current guidelines
Sham Insole
SHAM COMPARATORThis group will receive a Sham shoe insole without any specific custom-made design. The group will also receive Physiotherapy and Occupational Therapy according to current guidelines
Interventions
Subjects will receive a custom-made shoe insole designed on the patient's foot and shoes. The subjects should wear the insole for at least 6 hours per day.
Subjects will receive a conventional insole without any specific property (sham insole)
Eligibility Criteria
You may qualify if:
- Subjects with Idiopathic Parkinson's Disease;
- Age \> 18 years;
- Subjects should be in a positive therapeutic window or in the ON phase during the evaluations;
- Subjects must be able to walk at least 10 meters independently with or without any walking aid.
You may not qualify if:
- Not clinical stable subjects;
- SUbjects in OFF phase during the evaluations;
- Other neurological conditions (e.g. stroke, peripheral neuropathies, etc.);
- Other pathologies that can negatively influence the subject's walking ability (e.g. surgery at the lower limbs in the previous 6 months, important deformities at the lower limbs, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Fondazione Don Carlo Gnocchi
Milan, 20148, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 17, 2021
Study Start
March 4, 2021
Primary Completion
December 31, 2022
Study Completion
March 30, 2023
Last Updated
October 3, 2023
Record last verified: 2023-09